Product Information
CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0215 per EA under NDC 16571078250. Its NADAC has been published 244 times since Dec 22, 2021.
FDA first approved this application on Sep 26, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078250
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CYCLOBENZAPRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078643FDA Approved
9/26/2008
TE Code
AB
On Market Since
9/26/2008
Pharmacological Classes
Price Statistics
The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 244 times since Dec 22, 2021, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0215 per EA |
|---|---|
| All-time high | $0.0303 (Feb 16, 2022) |
| All-time low | $0.0157 (Nov 20, 2024) |
| 52-week high | $0.0219 |
| 52-week low | $0.0209 |
| Median price | $0.0220 |
| Average price | $0.0228 |
| Largest weekly change | +36.3% (Aug 21, 2024) |
| Weeks tracked | 244 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0215 per EA (NDC 16571078250), effective Aug 19, 2026.
How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 28.8%. It has been tracked across 244 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?
Since Dec 22, 2021, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0303 (Feb 16, 2022), with a median of $0.0220 per EA.
Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CYCLOBENZAPRINE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CYCLOBENZAPRINE 5 MG TABLET?
CYCLOBENZAPRINE 5 MG TABLET (NDC 16571078250) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.